Effect of intranasal fluticasone propionate on eotaxin in perennial allergic rhinitis

Guo-jun LIU,Ru-xin ZHANG,Zhi-Qiang YAN,Jun-zhi JIANG,Wu WEN,Xiao-hua SHEN,Shao-qing YU,Ge-ping WU
DOI: https://doi.org/10.3321/j.issn:0258-879X.2005.07.024
2005-01-01
Academic Journal of Second Military Medical University
Abstract:Objective: To investigate the effect of intranasal fluticasone propionate on chemokine eotaxin in patients with perennial allergic rhinitis (PAR). Methods: Levels of eotaxin in serum and nasal secretion were determined by ELISA in 25 PAR patients before and after they were treated with intranasal fluticasone propionate, and the results were compared with those of the normal controls. Results: The level of eotaxin in serum and nasal secretion of PAR patients was significantly higher than that of the normal controls (P0.05). After treatment with intranasal fluticasone propionate, the clinic symptoms and signs were alleviated and the level of eotaxin in serum and nasal secretion was decreased significantly (P0.05), to a level even lower than that of the normal controls. Conclusion: These results indicate that intranasal fluticasone propionate can decrease the level of eotaxin in PAR and alleviate allergic inflammation in nasal mucosa.
What problem does this paper attempt to address?